Access

Article


Nature Medicine 10, 594 - 601 (2004)
Published online: 23 May 2004 | doi:10.1038/nm1052

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

Pradip K Majumder1,2, Phillip G Febbo1,2, Rachel Bikoff1,2, Raanan Berger1,2, Qi Xue1,2, Louis M McMahon3, Judith Manola1, James Brugarolas1,2, Timothy J McDonnell4, Todd R Golub1,2,5, Massimo Loda1,2, Heidi A Lane6 & William R Sellers1,2,5


Loss of PTEN function leads to activation of phosphoinositide 3-kinase (PI3K) signaling and Akt. Clinical trials are now testing whether mammalian target of rapamycin (mTOR) inhibition is useful in treating PTEN-null cancers. Here, we report that mTOR inhibition induced apoptosis of epithelial cells and the complete reversal of a neoplastic phenotype in the prostate of mice expressing human AKT1 in the ventral prostate. Induction of cell death required the mitochondrial pathway, as prostate-specific coexpression of BCL2 blocked apoptosis. Thus, there is an mTOR-dependent survival signal required downstream of Akt. Bcl2 expression, however, only partially restored intraluminal cell growth in the setting of mTOR inhibition. Expression profiling showed that Hif-1alpha targets, including genes encoding most glycolytic enzymes, constituted the dominant transcriptional response to AKT activation and mTOR inhibition. These data suggest that the expansion of AKT-driven prostate epithelial cells requires mTOR-dependent survival signaling and activation of HIF-1alpha, and that clinical resistance to mTOR inhibitors may emerge through BCL2 expression and/or upregulation of HIF-1alpha activity.


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

TORward AKTually useful mouse models

Nature Medicine News and Views (01 Jun 2004)

Oxygen deprivation provokes melanoma

Nature Medicine News and Views (01 Feb 2006)